Two Big Factors Hurting Biotech ETFs

Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday. Biotech sector stocks were among the worst performing areas of the market Tuesday. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotech...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.